Supriya Announce Agreement To Market Plasma Nutrition’s IoProtein In India

Mumbai : API company Supriya Lifescience has announced a recent collaboration with Plasma Nutrition, a US-based nutrition company located in Delaware.

The strategic partnership involves an exclusive technology licensing agreement, granting Supriya Lifescience the sole rights for manufacturing and marketing Ingredient Optimised Protein (ioProtein) in India.

The primary purpose of this collaboration is to bring the optimised protein into the Indian market. ioProtein is a patented process (patent pending in the US) This revolutionary protein powder is designed for use as protein supplements and boasts a significant advantage, and it is highly bioavailable. This means that higher amounts of proteins are absorbed quickly by the body, providing consumers with a more effective and efficient protein supplement.

During the term of the agreement, Supriya Lifescience will lead the manufacturing and marketing of ioProtein in India. This marks the introduction of a new category of protein powders in the Indian market, and it is relatively healthier compared to other popular protein powders available through various gyms, general stores, and digital marketing channels.

“We are thrilled to be the exclusive partner of Plasma Nutrition, in introducing the innovative ioProtein to the Indian market,” said Dr Saloni Wagh, Executive Director at Supriya Lifescience.

“This strategic partnership represents our commitment to providing high-nutrition solutions to consumers in India. With ioProtein’s high bioavailability and its unmatched advantage, we are confident that the ‘IO’ technology will revolutionise the nutrition industry and become the preferred choice for health-conscious individuals,” Dr Wagh added.

“We are excited to collaborate with Supriya Lifescience and bring our patented ioProtein technology to India,” said Chris Flynn-Rozanski, co-founder & CEO at Plasma Nutrition.

“India’s rapidly growing demand for protein supplements present an excellent opportunity for us to introduce this highly bioavailable protein powder, which has already been well-received in other markets. We believe this partnership will create a new standard for protein supplementation in India,” Flynn-Rozanski said.

Related Posts

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

Gleneagles BGS Hospital, Kengeri, Bengaluru, part of the Fortis Healthcare Network, marked World Organ Donation Day with its annual commemorative event, ‘A Legacy That Lives On.’ The event brought together…

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

Punjab: The Narcotics Control Bureau (NCB) has uncovered an alleged pharmaceutical-drug diversion network operating through rural areas of Punjab. Investigators are tracing the movement of fentanyl and other drugs regulated…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

Bombay HC tells Maharashtra FDA to be ‘judicious’ after Cadila challenges order to ban sale of some medicines

Bombay HC tells Maharashtra FDA to be ‘judicious’ after Cadila challenges order to ban sale of some medicines

‘Erring pharma companies’: Over 1,000 cough syrup manufacturers undergo intense audits

‘Erring pharma companies’: Over 1,000 cough syrup manufacturers undergo intense audits

Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses